Literature DB >> 12633853

The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site.

Rik Gijsbers1, Junken Aoki, Hiroyuki Arai, Mathieu Bollen.   

Abstract

Autotaxin (NPP2) is a tumor cell motility-stimulating factor that displays both a nucleotide pyrophosphatase/phosphodiesterase activity and a recently described lysophospholipase D activity. The hydrolysis of nucleotides is a metal-assisted reaction that occurs via a nucleotidylated threonine in the catalytic site. We show here that the catalytic site threonine and the metal-coordinating residues are also essential for the hydrolysis of lysophospholipids. In comparing the substrate specificity of NPP2 and the closely related NPP1 and NPP3, we found that only NPP2 displayed a lysophospholipase D activity, whereas NPP1 and NPP3 had a much higher nucleotide pyrophosphatase activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12633853     DOI: 10.1016/s0014-5793(03)00133-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  34 in total

1.  Methylene ATP analogs as modulators of extracellular ATP metabolism and accumulation.

Authors:  Sheldon M Joseph; Matthew A Pifer; Ronald J Przybylski; George R Dubyak
Journal:  Br J Pharmacol       Date:  2004-06-21       Impact factor: 8.739

2.  Substrate-specifying determinants of the nucleotide pyrophosphatases/phosphodiesterases NPP1 and NPP2.

Authors:  Anisoara Cimpean; Cristiana Stefan; Rik Gijsbers; Willy Stalmans; Mathieu Bollen
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

3.  Synthesis and evaluation of fluorogenic substrates for phospholipase D and phospholipase C.

Authors:  Tyler M Rose; Glenn D Prestwich
Journal:  Org Lett       Date:  2006-06-08       Impact factor: 6.005

Review 4.  Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression.

Authors:  Lorenzo Federico; Kang Jin Jeong; Christopher P Vellano; Gordon B Mills
Journal:  J Lipid Res       Date:  2015-05-14       Impact factor: 5.922

Review 5.  The roles of autotaxin/lysophosphatidic acid in immune regulation and asthma.

Authors:  Seung-Jae Kim; Hyung-Geun Moon; Gye Young Park
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-01-29       Impact factor: 4.698

6.  Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion.

Authors:  Lauren P Saunders; Amy Ouellette; Russ Bandle; William Chozen Chang; Hongwen Zhou; Raj N Misra; Enrique M De La Cruz; Demetrios T Braddock
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

7.  Phosphodiesterase-Ialpha/autotaxin's MORFO domain regulates oligodendroglial process network formation and focal adhesion organization.

Authors:  Jameel Dennis; Michael A White; Audrey D Forrest; Larra M Yuelling; Luciana Nogaroli; Fatemah S Afshari; Michael A Fox; Babette Fuss
Journal:  Mol Cell Neurosci       Date:  2007-11-12       Impact factor: 4.314

Review 8.  Therapeutic potential of autotaxin/lysophospholipase d inhibitors.

Authors:  Lorenzo Federico; Zehra Pamuklar; Susan S Smyth; Andrew J Morris
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

9.  Functional studies of human intestinal alkaline sphingomyelinase by deglycosylation and mutagenesis.

Authors:  Jun Wu; Gert H Hansen; Ake Nilsson; Rui-Dong Duan
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

10.  A Not-So-Little Role for Lipoprotein(a) in the Development of Calcific Aortic Valve Disease.

Authors:  Maximillian A Rogers; Elena Aikawa
Journal:  Circulation       Date:  2015-07-29       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.